I suspect insider trading in advance of an announcement possibly to do with a merger or aquisition.The Company is well placed with cash in the bank and an approved loan facility.
NEU Neuren Pharmaceuticals dips after pediatric Angelman Syndrome Phase 2 trial results fail to impress
Week 32 Wrap: AI is clearly overhyped – but did we see ‘bubble’ burst already? Plus RBA decision; Japan’s wild week & Google ruling